Caris, Oncologist Group Create Cancer Molecular Profiling Program | GenomeWeb

NEW YORK (GenomeWeb) – Oncologist group Valley Medical Oncology Consultants and Caris Life Sciences will establish a clinical molecular profiling program to serve cancer patients in the San Francisco Bay Area, they announced today.

The collaboration will use Caris Molecular Intelligence, a tumor profiling service to identify target therapies for patients based on their unique cancer biology. The service integrates molecular data generated from a patient's tumor into a report that includes biomarkers that are associated with therapies and/or available clinical trials.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.